You are here

Biblio

Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is I  [Clear All Filters]
2021
He Z, Liu L, Wang C, Le Guen Y, Lee J, Gogarten S, Lu F, Montgomery S, Tang H, Silverman EK et al..  2021.  Identification of putative causal loci in whole-genome sequencing data via knockoff statistics.. Nat Commun. 12(1):3152.
Baird DA, Liu JZ, Zheng J, Sieberts SK, Perumal T, Elsworth B, Richardson TG, Chen C-Y, Carrasquillo MM, Allen M et al..  2021.  Identifying drug targets for neurological and psychiatric disease via genetics and the brain transcriptome.. PLoS Genet. 17(1):e1009224.
Xu H, O'Reilly M, Gibbons GS, Changolkar L, McBride JD, Riddle DM, Zhang B, Stieber A, Nirschl J, Kim S-J et al..  2021.  In vitro amplification of pathogenic tau conserves disease-specific bioactive characteristics.. Acta Neuropathol. 141(2):193-215.
Griswold AJ, Celis K, Bussies PL, Rajabli F, Whitehead PL, Hamilton-Nelson KL, Beecham GW, Dykxhoorn DM, Nuytemans K, Wang L et al..  2021.  Increased APOE ε4 expression is associated with the difference in Alzheimer's disease risk from diverse ancestral backgrounds.. Alzheimers Dement. 17(7):1179-1188.
Wingo AP, Liu Y, Gerasimov ES, Gockley J, Logsdon BA, Duong DM, Dammer EB, Robins C, Beach TG, Reiman EM et al..  2021.  Integrating human brain proteomes with genome-wide association data implicates new proteins in Alzheimer's disease pathogenesis.. Nat Genet. 53(2):143-146.
Novikova G, Kapoor M, Tcw J, Abud EM, Efthymiou AG, Chen SX, Cheng H, Fullard JF, Bendl J, Liu Y et al..  2021.  Integration of Alzheimer's disease genetics and myeloid genomics identifies disease risk regulatory elements and genes.. Nat Commun. 12(1):1610.
Panitch R, Hu J, Chung J, Zhu C, Meng G, Xia W, Bennett DA, Lunetta KL, Ikezu T, Au R et al..  2021.  Integrative brain transcriptome analysis links complement component 4 and HSPA2 to the APOE ε2 protective effect in Alzheimer disease.. Mol Psychiatry. 26(10):6054-6064.
2020
Griswold AJ, Sivasankaran SK, Van Booven D, Gardner OK, Rajabli F, Whitehead PL, Hamilton-Nelson KL, Adams LD, Scott AM, Hofmann NK et al..  2020.  Immune and Inflammatory Pathways Implicated by Whole Blood Transcriptomic Analysis in a Diverse Ancestry Alzheimer's Disease Cohort.. J Alzheimers Dis. 76(3):1047-1060.
Ayata P, Schaefer A.  2020.  Innate sensing of mechanical properties of brain tissue by microglia.. Curr Opin Immunol. 62:123-130.
Weitzman SA, Narasimhan S, He Z, Changolkar L, McBride JD, Zhang B, Schellenberg GD, Trojanowski JQ, M Y Lee V.  2020.  Insoluble Tau From Human FTDP-17 Cases Exhibit Unique Transmission Properties In Vivo.. J Neuropathol Exp Neurol. 79(9):941-949.
Devanand DP, Lee S, Luchsinger JA, Andrews H, Goldberg T, Huey ED, Schupf N, Manly J, Stern Y, Kreisl WC et al..  2020.  Intact global cognitive and olfactory ability predicts lack of transition to dementia.. Alzheimers Dement. 16(2):326-334.
Ajnakina O, Cadar D, Steptoe A.  2020.  Interplay between Socioeconomic Markers and Polygenic Predisposition on Timing of Dementia Diagnosis.. J Am Geriatr Soc. 68(7):1529-1536.
Andrews SJ, Fulton-Howard B, Goate A.  2020.  Interpretation of risk loci from genome-wide association studies of Alzheimer's disease.. Lancet Neurol. 19(4):326-335.
Lee J, Dey AB.  2020.  Introduction to LASI-DAD: The Longitudinal Aging Study in India-Diagnostic Assessment of Dementia.. J Am Geriatr Soc. 68 Suppl 3:S3-S4.

Theme by Danetsoft and Danang Probo Sayekti inspired by Maksimer